Summary of preclinical trials of GLP1R agonists for PD 6-OHDA: 6-hydroxydopamine, BID: twice a day, Ex-4: Exendin-4, MPTP: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, PD: Parkinsons disease, LPS: lipopolysaccharide, GLP1R: glucagon-like peptide-1 receptor
Studies suggest that supporting glutathione status may help defend against cataract formation
After Opening: For multi-dose vials of B12 injections, there is always a specific shelf life after the vial has been opened
Enhancing GSH, mainly through NAC, GSH precursors rich in cysteine (whey protein, whey protein isolate rich in cysteine) or pro-GSH compound administration, becomes a potential treatment option for inflammatory diseases by reducing oxidative stress and cytokine expression especially in diabetic patients that also are at risk of more severe COVID-19 disease (299)
This is one reason proactive hydration and symptom management are not optional
Pauls, D